RecruitingNCT05306184

Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA

This recruiting study focuses on depression and currently lists sites or participation links in Netherlands.

DepressionProcedureOver 18 Years

In plain English

Key information made simple

This study exists to learn from real-world information that can show how a medication treatment fits into care. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning. For people living with Depression, small gains in stability can make a meaningful difference over time. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including GGz inGeest in Amsterdam and RadboudUMC in Nijmegen. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually having a stable enough treatment background for the study and meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results and major medical issues that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT05306184. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Netherlands.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com